Study finds one shot of HPV vaccine just as effective as two; cervical cancer screening guidelines updated
A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical cancer. The study, led by the National Cancer Institute, consisted of a randomized trial of 20,320 girls ages 12-16. In addition, the American Cancer Society Dec. 4 announced updated guidelines for cervical cancer screening, saying that self-collection of vaginal samples for HPV testing is now optional, although clinician-collected samples are preferred.
Related News Articles
Headline
A study conducted by the University of Utah examined variations in risk behaviors for colorectal, cervical and breast cancer and trends in screening across…
Headline
The Department of Health and Human Services Oct. 27 announced a new initiative to improve breast cancer screening and detection efforts. The initiative, led by…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
A survey released Sept. 10 by the National Comprehensive Cancer Network highlights ongoing shortages of cancer medications. All responding cancer centers…
Headline
In this conversation, Kardie Tobb, D.O., a non-invasive preventative cardiologist at Cone Health, explains how multidisciplinary teams are breaking down…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…